Sinovac Biotech Gets Positive Decision from WHO on Healive

Adverum Bio Initiates Advance Phase 1/2 Trial of ADVM-043

Odonate Begins Phase 3 Study of Tesetaxel

NeuClone Discloses Details of Denosumab' Biosimilar Candidate

Frutarom Acquires AB-Fortis

Researchers Explore Complex Genetic Network behind Sleep Duration

Glenmark's Phase 3 Safety Study Evaluating Ryaltris in Patients with PAR Meets Primary Endpoint

Daiichi Sankyo, Puma Biotech Sign Research Pact with MSK Cancer Centre

BIRAC Invites Research Proposals in the Areas of Vaccines, Biotherapeutics

Karnataka Woos Scientists and Entrepreneurs

US FDA Accepts Ascentage's IND Application for APG-1387

Bayer, PeptiDream Ink Global Drug Discovery Pact

GVK BIO Completes 10 Year Collaboration with Nuevolution

GNA Biosolutions to Introduce Pharos V8 for In Vitro Research Use

Noxxon Pharma Inks Deal with NCT in Heidelberg

Biogen Buys Remedy Pharma's CIRARA

ix Biopharma Reports Positive Results from Pharmacokinetic Study of Bnox

Seres Therapeutics to Initiate New SER-109 Phase 2 Study

Amarantus to Acquire Certain Biotech Assets from SeD BioMedical

USPTO Grants Patent for Kadimastem Cell Based Treatment

Pharnext Initiates Phase 3 Extension Study PLEO-CMT-FU of PXT3003

Sanofi, Lonza Collaborate to Set up Large-scale Biologics Production Unit

Researchers Find Novel Target for Controlling Immune Response to Implanted Materials